Location History:
- Stone Mountain, GA (US) (1995 - 1998)
- Brentwood, TN (US) (2003 - 2014)
- West Palm Beach, FL (US) (2023)
Company Filing History:
9 out of 1,155 
3 out of 987 
2 out of 2,010 
Years Active: 1995-2023
Title: Randy D. Blakely: A Pioneer in Addiction Research and Neurotransmitter Transport
Introduction
Randy D. Blakely is an esteemed inventor based in Brentwood, TN, recognized for his significant contributions to the fields of addiction research and neurotransmitter transport. With a remarkable portfolio of 10 patents, Blakely's innovations reflect his commitment to addressing critical challenges in substance abuse treatment.
Latest Patents
Among his latest inventions are methods designed to identify treatments that counteract the effects of substance abuse and addiction. His research highlights the significance of MBLAC1 as a targeted therapeutic option. These methods include using assays to assess whether a test agent can bind to MBLAC1 or disrupt its interaction with Ceftriaxone (Cef), marking such agents as potential candidates for treating addiction. Moreover, his work encompasses the use of MBLAC knock-out animals and various kits aimed at discovering therapeutic agents that mitigate the actions of substances of abuse.
Additionally, Blakely's innovative approach to neurotransmitter transport is showcased through his patent for fluorescent substrates. This invention, based on the discovery that IDT307 and its analogs are excellent substrates for several neurotransmitter transporters, provides methodologies for analyzing neurotransmitter transport and binding, greatly enhancing the screening process for modulators of neurotransmitter transport.
Career Highlights
Randy D. Blakely has had a distinguished career, primarily affiliated with Vanderbilt University. His research endeavors have not only advanced scientific knowledge but have also contributed to potential real-world applications in addiction treatment.
Collaborations
Throughout his career, Blakely has collaborated with notable peers such as John N. Mason and Ian D. Tomlinson. These partnerships have undoubtedly enriched his research and expanded the impact of his innovative work.
Conclusion
Randy D. Blakely stands out as a prominent inventor whose work continues to influence the landscape of addiction research and treatment. His dedication to developing methods that align with scientific rigor and therapeutic potential highlights the vital role of innovation in addressing urgent societal challenges.